Beam Therapeutics Inc. (BEAM) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2019: $12.52M2020: $16.36M2021: $46.81M2022: $48.95M2023: $33.73M2024: $8.95M2025: $14.95M$14.95M
2019Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$14.95M+67.1%
2024$8.95M-73.5%
2023$33.73M-31.1%
2022$48.95M+4.6%
2021$46.81M+186.2%
2020$16.36M+30.7%
2019$12.52M